We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$44.4B
AUM Growth
+$1.2B
Cap. Flow
+$3.32B
Cap. Flow %
7.48%
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$555M
2
LLY icon
Eli Lilly
LLY
+$536M
3
META icon
Meta Platforms (Facebook)
META
+$433M
4
PGR icon
Progressive
PGR
+$330M
5
LRCX icon
Lam Research
LRCX
+$294M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 15.38%
3 Financials 14.3%
4 Consumer Discretionary 11.43%
5 Industrials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTE icon
1726
Astec Industries
ASTE
$1.17B
$562K ﹤0.01%
16,319
-2,100
-11% -$72.2K
MBI icon
1727
MBIA
MBI
$275M
$558K ﹤0.01%
112,050
-11,800
-10% -$73K
ALK icon
1728
Alaska Air
ALK
$5.11B
$556K ﹤0.01%
+11,300
New +$742K
FIP icon
1729
FTAI Infrastructure
FIP
$447M
$555K ﹤0.01%
122,500
-67,000
-35% -$419K
ANDE icon
1730
Andersons Inc
ANDE
$2.39B
$554K ﹤0.01%
12,900
+5,400
+72% +$229K
EH
1731
EHang Holdings
EH
$375M
$554K ﹤0.01%
+26,500
New +$538K
AXTI icon
1732
AXT Inc
AXTI
$2.42B
$553K ﹤0.01%
391,900
-282,500
-42% -$540K
DEI icon
1733
Douglas Emmett
DEI
$2.05B
$552K ﹤0.01%
34,500
-5,200
-13% -$88.2K
PHIN icon
1734
Phinia Inc
PHIN
$3.04B
$552K ﹤0.01%
13,000
+200
+2% +$9.58K
ALKT icon
1735
Alkami Technology
ALKT
$1.96B
$551K ﹤0.01%
+21,000
New +$661K
PMVP icon
1736
PMV Pharmaceuticals
PMVP
$57.1M
$551K ﹤0.01%
505,600
-209,000
-29% -$284K
ACIW icon
1737
ACI Worldwide
ACIW
$6.12B
$547K ﹤0.01%
10,000
-2,500
-20% -$133K
TCMD icon
1738
Tactile Systems Technology
TCMD
$618M
$546K ﹤0.01%
+41,300
New +$650K
LRN icon
1739
Stride
LRN
$4.16B
$544K ﹤0.01%
+4,300
New +$543K
BLZE icon
1740
Backblaze
BLZE
$683M
$542K ﹤0.01%
112,300
-62,200
-36% -$383K
VMD icon
1741
Viemed Healthcare
VMD
$447M
$542K ﹤0.01%
74,400
+60,700
+443% +$477K
IRBT
1742
DELISTED
iRobot
IRBT
$541K ﹤0.01%
200,200
-377,900
-65% -$2.73M
WIT icon
1743
Wipro
WIT
$19.5B
$540K ﹤0.01%
176,600
-7,900
-4% -$26.9K
CLF icon
1744
Cleveland-Cliffs
CLF
$6.49B
$538K ﹤0.01%
+65,500
New +$666K
OCUL icon
1745
Ocular Therapeutix
OCUL
$1.83B
$536K ﹤0.01%
73,100
+36,400
+99% +$280K
CMRE icon
1746
Costamare
CMRE
$1.85B
$535K ﹤0.01%
54,400
-66,100
-55% -$729K
NX icon
1747
Quanex
NX
$825M
$535K ﹤0.01%
28,772
+14,600
+103% +$309K
HMY icon
1748
Harmony Gold Mining
HMY
$9.7B
$532K ﹤0.01%
36,000
-109,100
-75% -$1.22M
TSEM icon
1749
Tower Semiconductor
TSEM
$21.2B
$531K ﹤0.01%
14,900
-26,300
-64% -$1.19M
HVT icon
1750
Haverty Furniture Companies
HVT
$418M
$530K ﹤0.01%
26,900
+14,300
+113% +$313K

Similar funds

Two Sigma Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Two Sigma Advisers held 2,641 positions worth $44.4B, up 2.8% from $43.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Two Sigma Advisers deployed $3.32B of net new capital in Q1 2025, opening 312 new positions and adding to 1,037 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 553,800 shares worth $351M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $555M trimmed.

  • Two Sigma Advisers's largest Q1 2025 buy was Regeneron Pharmaceuticals: 553,800 shares worth $351M.
  • Two Sigma Advisers added most to Broadcom in Q1 2025, an estimated $519M increase.
  • Two Sigma Advisers's biggest Q1 2025 reduction was Visa, cutting an estimated $555M.
  • Two Sigma Advisers fully exited Abbott in Q1 2025, selling an estimated $158M.
  • Two Sigma Advisers's ten largest holdings make up 18% of its $44.4B portfolio in Q1 2025.
  • Two Sigma Advisers opened 312 new positions and closed 281 in Q1 2025.
  • Two Sigma Advisers's portfolio value rose 2.8% quarter-over-quarter to $44.4B.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.